Calamos Wealth Management LLC bought a new position in UnitedHealth Group Inc. (NYSE:UNH) during the second quarter, Holdings Channel reports. The firm bought 42,342 shares of the healthcare conglomerate’s stock, valued at approximately $5,979,000. UnitedHealth Group comprises about 1.1% of Calamos Wealth Management LLC’s portfolio, making the stock its 22nd largest position.
Several other hedge funds and other institutional investors have also bought and sold shares of UNH. MCF Advisors LLC raised its position in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 726 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its position in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares in the last quarter. Evanson Asset Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter worth approximately $201,000. Parametrica Management Ltd purchased a new position in shares of UnitedHealth Group during the second quarter worth approximately $201,000. Finally, Franklin Street Advisors Inc. NC purchased a new position in shares of UnitedHealth Group during the second quarter worth approximately $208,000. 85.78% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Inc. (NYSE:UNH) traded up 1.21% during midday trading on Friday, reaching $140.00. The company had a trading volume of 4,164,080 shares. UnitedHealth Group Inc. has a one year low of $107.51 and a one year high of $144.48. The stock has a market capitalization of $133.33 billion, a price-to-earnings ratio of 21.91 and a beta of 0.57. The company has a 50-day moving average price of $138.43 and a 200-day moving average price of $135.92.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.89 by $0.07. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The firm earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. On average, equities analysts expect that UnitedHealth Group Inc. will post $7.92 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were issued a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s payout ratio is currently 39.12%.
UNH has been the topic of a number of research reports. Leerink Swann reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Credit Suisse Group AG reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Sanford C. Bernstein initiated coverage on UnitedHealth Group in a report on Wednesday, June 15th. They issued an “outperform” rating and a $171.00 price objective on the stock. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, June 21st. Finally, Wolfe Research initiated coverage on UnitedHealth Group in a report on Tuesday, June 28th. They issued an “outperform” rating and a $172.00 price objective on the stock. One analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $154.96.
In other news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.65% of the stock is owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.